Georgia Stimpson is currently a PhD student in applied biostatistics at UCL's Institute of Child Health, Great Ormond Street Hospital. She works primarily on data from two rare neuromuscular diseases, Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA1). Her research is focused on how multidimensional disease data collected longitudinally can be used to understand variation in both disease trajectory and treatment response.
Her research at the Turing relates specifically to understanding variation in reaction to treatment in patients with SMA Type 1 (SMA1). Historically, children with SMA1 were never able to sit independently, but thanks to recent pharmaceutical developments there are now three drugs available which massively alter disease progression. Patient response to treatment is varied, and so it is not yet clear which patients should get which drug. My project looks at one of these drugs, Nusinersen, and will use biomarker, medical and motor function information collected at baseline and during the first 6 months of treatment to explain the variability in treatment response. This will form the first step in constructing optimal treatment rules for SMA1 patients.